Drug Profile
Verpasep caltespen
Alternative Names: BCG65-E7; HspE7; Oncocine HspE7; R1461; SGN-00101Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Nventa Biopharmaceuticals Corporation
- Developer Akela Pharma
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants; Toll-like receptor 3 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anal dysplasia; Cervical cancer; Cervical dysplasia; Cervical intraepithelial neoplasia; Human papillomavirus infections; Recurrent respiratory papillomatosis